Dengue Vaccine Global Market Opportunities And Strategies To 2034
상품코드:1695941
리서치사:The Business Research Company
발행일:2025년 03월
페이지 정보:영문 294 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
전 세계 뎅기열 백신 시장 규모는 2019년 260만 달러로 2024년까지 174.00% 이상의 CAGR로 성장할 것으로 예상됩니다.
뎅기열 발병률 증가
뎅기열 발병률의 증가는 과거 기간 동안 뎅기열 백신 시장의 성장을 뒷받침했습니다. 뎅기열 환자가 급증함에 따라 정부, 의료 기관 및 개인은 효과적인 예방 전략을 우선순위에 두고 있습니다. 백신 접종은 특히 모기 매개 질병에 취약한 지역에서 뎅기열 발생을 관리하는 데 있어 매우 중요한 솔루션으로 부상하고 있습니다. 이러한 전염병은 입원, 의료 치료, 노동 생산성 저하로 인해 막대한 의료 비용과 경제적 혼란을 초래하는 경우가 많습니다. 따라서 이해관계자들은 백신 접종이 이 질병의 전반적인 영향을 줄일 수 있는 비용 효율적인 접근법이라고 인식하고 있습니다. 예를 들어, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)에 따르면, 2024년 5월, 아메리카 지역의 뎅기열 환자 수가 700만 명을 넘어섰으며, 2023년에 기록된 460만 명에서 크게 증가했습니다. 따라서 뎅기열 발병률의 증가는 뎅기열 백신 시장의 성장을 촉진했습니다.
세계의 뎅기열 백신 시장에 대해 조사 분석했으며, 시장의 특징과 주요 시장 동향, 시장 규모와 성장 전망, 경쟁 구도 등의 정보를 전해드립니다.
목차
제1장 주요 요약
뎅기열 백신 - 시장 매력과 거시경제 상황
제2장 목차
제3장 표목차
제4장 그림목차
제5장 보고서 구성
제6장 시장 특징
일반적인 시장 정의
요약
뎅기열 백신 시장 정의와 세분화
시장 세분화 : 유형별
생 백신
불활화 백신
아단위 백신
핵산 백신
시장 세분화 : 투여 경로별
경구
비경구
기타 치료
시장 세분화 : 최종사용자별
병원
진료소
정부기관
비정부 조직
기타 최종사용자
제7장 주요 시장 동향
뎅기열 감염 조기 발견을 위한 진단키트 발전
전 세계 뎅기열 발병률 증가에 대응하는 새로운 뎅기열 치료 솔루션에 투자
뎅기열 백신 시장에서 혁신을 촉진하는 전략적 파트너십 체결
제8장 뎅기열 백신 시장 - 거시경제 시나리오
뎅기열 백신 시장에 대한 COVID-19의 영향
뎅기열 백신 시장에 대한 우크라이나 전쟁의 영향
뎅기열 백신 시장에 대한 고인플레이션의 영향
제9장 세계의 시장 규모와 성장
시장 규모
시장 성장 실적(2019-2024년)
시장 성장 촉진요인(2019-2024년)
시장 성장 억제요인(2019-2024년)
시장 성장 예측(2024-2029년·2034년)
시장 성장 촉진요인(2024-2029년)
시장 성장 억제요인(2024-2029년)
제10장 세계의 뎅기열 백신 시장 세분화
세계의 뎅기열 백신 시장 : 유형별, 실적과 예측(2019-2024년·2029년·2034년)
세계의 뎅기열 백신 시장 : 투여 경로별, 실적과 예측(2019-2024년·2029년·2034년)
세계의 뎅기열 백신 시장 : 최종사용자별, 실적과 예측(2019-2024년·2029년·2034년)
제11장 뎅기열 백신 시장, 지역과 국가 분석
세계의 뎅기열 백신 시장 : 지역별, 실적과 예측(2019-2024년·2029년·2034년)
세계의 뎅기열 백신 시장 : 국가별, 실적과 예측(2019-2024년·2029년·2034년)
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 개요
기업 개요
Takeda Pharmaceutical Company Limited
Sanofi S.A.
GlaxoSmithKline plc
Merck & Co., Inc.
Panacea Biotec Ltd
제20장 기타 주요 기업과 혁신적 기업
Codagenix Inc
Serum Institute of India
Inovio Pharmaceuticals Inc
Novavax, Inc
Medigen Vaccine Biologics Corporation
The International Vaccine Institute(ivi.int)
Bharat Biotech International Limited
Sinovac Biotech Ltd
SABIN Vaccine Institute Inc
VabioTech
BioNet-Asia Co. Ltd
Hilleman Laboratories Pvt. Ltd
Biological E. Limited
K.M. Biologics
Emergex
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 기회와 전략
세계의 뎅기열 백신 시장 - 가장 새로운 기회를 제공하는 국가(2029년)
세계의 뎅기열 백신 시장 - 가장 새로운 기회를 제공하는 부문(2029년)
세계의 뎅기열 백신 시장 - 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제24장 뎅기열 백신 시장 : 결론과 제안
결론
제안
제품
유통
가격
프로모션
사람들
제25장 부록
ksm
영문 목차
영문목차
A dengue vaccine is a biological preparation designed to protect individuals against dengue fever, a viral infection caused by the dengue virus (DENV). This virus is transmitted primarily through the bite of infected Aedes mosquitoes, especially Aedes aegypti. Dengue fever causes a range of symptoms, from mild flu-like illness to severe complications such as dengue hemorrhagic fever and dengue shock syndrome, which can be life-threatening.
The dengue vaccine market consists of sales by entities (organizations, sole traders and partnerships) of dengue vaccine that focuses on providing solutions to mitigate the severe health risks associated with the disease, which can range from flu-like symptoms to life-threatening complications like dengue hemorrhagic fever and dengue shock syndrome.
The global dengue vaccine market was valued at $2.60 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 174.00%.
Rising Dengue Incidence
The rising dengue incidence supported the growth of the dengue vaccine market during the historic period. With the surge in dengue cases, governments, healthcare organizations and individuals are prioritizing effective prevention strategies. Vaccination emerges as a pivotal solution in managing dengue outbreaks, particularly in regions prone to mosquito-borne diseases. These outbreaks often result in substantial healthcare expenses and economic disruptions, driven by hospitalizations, medical care and decreased workforce productivity. Consequently, stakeholders recognize vaccination as a cost-efficient approach to mitigating the overall impact of the disease. For instance, in May 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in the American region, dengue cases surpassed 7 million in April 2024, a significant increase from the 4.6 million cases recorded in 2023. Therefore, the rising dengue incidence drove the growth of the dengue vaccine market.
Investment In Novel Dengue Treatment Solutions To Address Rising Global Incidence
Major companies operating in the dengue vaccine market are focusing on strategic investments to expand their product portfolios, enhance vaccine efficacy and improve global access. Strategic investments drive the growth of the dengue vaccine market by boosting funding for research and development, allowing manufacturers to develop more efficient and advanced vaccines. For instance, in October 2023, Codagenix Inc., a US-based clinical-stage biotechnology company focused on developing vaccines received an award of $5.88 million from U.S. Department of Defense (DoD) to further develop its dengue vaccine candidate, CodaVax-DENV. The funding will support the initiation of a first-in-human Phase 1 trial, which will evaluate the vaccine's safety and immunogenicity. This initiative aligns with a broader strategy to combat dengue fever, a significant health threat, particularly for military personnel deployed in endemic regions.
The global dengue vaccine market is highly concentrated, with few players operating in the market. The top ten competitors in the market made up to 100.0% of the total market in 2023.
Dengue Vaccine Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global dengue vaccine market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for dengue vaccine? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The dengue vaccine market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider dengue vaccine market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by route of administration and by end user.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the dengue vaccine market.
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by route of administration and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for dengue vaccine market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type: Live Attenuated Vaccine; Inactivated Vaccine; Subunit Vaccine; Nucleic Acid-Based Vaccine
2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
3) By End User: Hospitals; Clinics; Government Institutes; Non-Governmental Organizations; Other End-Users
10.1 Global Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.3 Global Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11 Dengue Vaccine Market, Regional and Country Analysis
11.1 Global Dengue Vaccine Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.2 Global Dengue Vaccine Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Asia-Pacific Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Asia-Pacific Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Asia-Pacific Dengue Vaccine Market: Country Analysis
12.7 China Market
12.8 Market Overview
12.8.1 Country Information
12.8.2 Market Information
12.8.3 Background Information
12.8.4 Government Initiatives
12.8.5 Regulations
12.8.6 Regulatory Bodies
12.8.7 Major Associations
12.8.8 Taxes Levied
12.8.9 Corporate Tax Structure
12.8.10 Major Companies
12.9 China Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 China Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 China Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 India Market
12.13 India Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 India Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 India Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 Japan Market
12.17 Japan Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Japan Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Japan Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 Australia Market
12.21 Australia Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Australia Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Australia Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 Indonesia Market
12.25 Indonesia Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Indonesia Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.27 Indonesia Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.28 South Korea Market
12.29 South Korea Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.30 South Korea Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.31 South Korea Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate tax structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Western Europe Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Western Europe Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Western Europe Dengue Vaccine Market: Country Analysis
13.7 UK Market
13.8 UK Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 UK Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 UK Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.11 Germany Market
13.12 Germany Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.13 Germany Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.14 Germany Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.15 France Market
13.16 France Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.17 France Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.18 France Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.19 Italy Market
13.20 Italy Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.21 Italy Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.22 Italy Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.23 Spain Market
13.24 Spain Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.25 Spain Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.26 Spain Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Regulations
14.2.5 Regulatory Bodies
14.2.6 Major Associations
14.2.7 Taxes Levied
14.2.8 Corporate Tax Structure
14.2.9 Major companies
14.3 Eastern Europe Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 Eastern Europe Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 Eastern Europe Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 Eastern Europe Dengue Vaccine Market: Country Analysis
14.7 Russia Market
14.8 Russia Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.9 Russia Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.10 Russia Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 North America Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 North America Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 North America Dengue Vaccine Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.1 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.11 USA Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.12 USA Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.13 Canada Market
15.14 Canada Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.15 Canada Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.16 Canada Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 South America Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 South America Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 South America Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.6 South America Dengue Vaccine Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.9 Brazil Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.10 Brazil Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Middle East Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Middle East Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Middle East Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18 Africa Market
18.1 Market Overview
18.1.1 Region Information
18.1.2 Market Information
18.1.3 Background Information
18.1.4 Government Initiatives
18.1.5 Regulations
18.1.6 Regulatory Bodies
18.1.7 Major Associations
18.1.8 Taxes Levied
18.1.9 Corporate Tax Structure
18.1.10 Major Companies
18.2 Africa Dengue Vaccine Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.3 Africa Dengue Vaccine Market, Segmentation By Route Of Administration, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.4 Africa Dengue Vaccine Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Takeda Pharmaceutical Company Limited
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Sanofi S.A.
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Financial Overview
19.4 GlaxoSmithKline plc
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Merck & Co., Inc.
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Panacea Biotec Ltd
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Other Major And Innovative Companies
20.1 Codagenix Inc
20.1.1 Company Overview
20.1.2 Products and Services
20.2 Serum Institute of India
20.2.1 Company Overview
20.2.2 Products And Services
20.3 Inovio Pharmaceuticals Inc
20.3.1 Company Overview
20.3.2 Products and Services
20.4 Novavax, Inc
20.4.1 Company Overview
20.4.2 Products And Services
20.5 Medigen Vaccine Biologics Corporation
20.5.1 Company Overview
20.5.2 Products and Services
20.6 The International Vaccine Institute (ivi.int)
20.6.1 Company Overview
20.6.2 Products and Services
20.7 Bharat Biotech International Limited
20.7.1 Company Overview
20.7.2 Products and Services
20.8 Sinovac Biotech Ltd
20.8.1 Company Overview
20.8.2 Products and Services
20.9 SABIN Vaccine Institute Inc
20.9.1 Company Overview
20.9.2 Products and Services
20.10 VabioTech
20.10.1 Company Overview
20.10.2 Products and Services
20.11 BioNet-Asia Co. Ltd
20.11.1 Company Overview
20.11.2 Products and Services
20.12 Hilleman Laboratories Pvt. Ltd
20.12.1 Company Overview
20.12.2 Products and Services
20.13 Biological E. Limited
20.13.1 Company Overview
20.13.2 Products and Services
20.14 K.M. Biologics
20.14.1 Company Overview
20.14.2 Products and Services
20.15 Emergex
20.15.1 Company Overview
20.15.2 Products and Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Opportunities And Strategies
23.1 Global Dengue Vaccine Market In 2029 - Countries Offering Most New Opportunities
23.2 Global Dengue Vaccine Market In 2029 - Segments Offering Most New Opportunities
23.3 Global Dengue Vaccine Market In 2029 - Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 Dengue Vaccine Market, Conclusions And Recommendations
